Compositional editing of extracellular matrices by CRISPR/Cas9 engineering of human mesenchymal stem cell lines
eLife · 28.03.2025 · 13
DOI: 10.7554/elife.96941 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 28.03.2025. Verfasst von Sujeethkumar Prithiviraj und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cell, Tissue & Organ Engineering Laboratory, BMC, Department of Clinical Sciences, Lund University, Lund, Sweden. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Mesenchymal Stem Cells, Extracellular Matrix, Gene Editing. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vetenskapsrådet, European Research Council, IngaBritt och Arne Lundbergs Forskningsstiftelse.
Abstract (Originalsprache)
Tissue engineering strategies predominantly rely on the production of living substitutes, whereby implanted cells actively participate in the regenerative process. Beyond cost and delayed graft availability, the patient-specific performance of engineered tissues poses serious concerns on their clinical translation ability. A more exciting paradigm consists in exploiting cell-laid, engineered extracellular matrices (eECMs), which can be used as off-the-shelf materials. Here, the regenerative capacity solely relies on the preservation of the eECM structure and embedded signals to instruct an endogenous repair. We recently described the possibility to exploit custom human stem cell lines for eECM manufacturing. In addition to the conferred standardization, the availability of such cell lines opened avenues for the design of tailored eECMs by applying dedicated genetic tools. In this study, we demonstrated the exploitation of CRISPR/Cas9 as a high precision system for editing the composition and function of eECMs. Human mesenchymal stromal/stem cell (hMSC) lines were modified to knock out vascular endothelial growth factor (VEGF) and Runt-related transcription factor 2 (RUNX2) and assessed for their capacity to generate osteoinductive cartilage matrices. We report the successful editing of hMSCs, subsequently leading to targeted VEGF and RUNX2-knockout cartilage eECMs. Despite the absence of VEGF, eECMs retained full capacity to instruct ectopic endochondral ossification. Conversely, RUNX2-edited eECMs exhibited impaired hypertrophy, reduced ectopic ossification, and superior cartilage repair in a rat osteochondral defect. In summary, our approach can be harnessed to identify the necessary eECM factors driving endogenous repair. Our work paves the road toward the compositional eECMs editing and their exploitation in broad regenerative contexts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cell, Tissue & Organ Engineering Laboratory, BMC, Department of Clinical Sciences, Lund University, Lund, Sweden.
- Wallenberg Centre for Molecular Medicine, Lund Stem Cell Centre, Lund University Cancer Centre, Lund University, Lund, Sweden.
- Department of Orthopaedics, Nanchong Central Hospital, The Second Clinical Institute of North Sichuan Medical College Nanchong, Sichuan, China.
- Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, Lund, Sweden.
- Division of Pediatrics, Clinical Sciences, Translational Cancer Research, Lund University Cancer Center at Medicon Village, Lund, Sweden.
- The Faculty of Medicine, Department of Clinical Sciences Lund, Orthopedics, Lund, Sweden.
ORCID-Profile: Sujeethkumar Prithiviraj, Sofie Mohlin, Paul E Bourgine
Förderung
- Vetenskapsrådet
- European Research Council
- IngaBritt och Arne Lundbergs Forskningsstiftelse
- Knut and Alice Wallenberg Foundation
- Lund University Medical Faculty Foundation
- Region Skåne
Zitieren
APA
Prithiviraj, S., Garcia Garcia, A., Linderfalk, K., Yiguang, B., Ferveur, S., Falck, L. N., Subramaniam, A., Mohlin, S., Hidalgo Gil, D., Dupard, S. J., Zacharaki, D., Raina, D. B., & Bourgine, P. E. (2025). Compositional editing of extracellular matrices by CRISPR/Cas9 engineering of human mesenchymal stem cell lines. eLife, 13. https://doi.org/10.7554/elife.96941
Vancouver
Prithiviraj S, Garcia Garcia A, Linderfalk K, Yiguang B, Ferveur S, Falck LN, et al. Compositional editing of extracellular matrices by CRISPR/Cas9 engineering of human mesenchymal stem cell lines. eLife. 2025;13. doi:10.7554/elife.96941
BibTeX
@article{Prithiviraj2025,
author = {Prithiviraj, Sujeethkumar and Garcia Garcia, Alejandro and Linderfalk, Karin and Yiguang, Bai and Ferveur, Sonia and Falck, Ludvig Nilsén and Subramaniam, Agatheeswaran and Mohlin, Sofie and Hidalgo Gil, David and Dupard, Steven J and Zacharaki, Dimitra and Raina, Deepak Bushan and Bourgine, Paul E},
title = {Compositional editing of extracellular matrices by CRISPR/Cas9 engineering of human mesenchymal stem cell lines},
journal = {eLife},
year = {2025},
volume = {13},
doi = {10.7554/elife.96941}
}
EUVIMED